Introduction/New Treatment Options to Improve Clinical Outcomes


Forgot your login? GET HELP

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

The l990s have already proved to be an exciting time in clinical psychopharmacology. New antipsychotic agents that offer improved therapeutic efficacy and better tolerability for our patients have become available. These agents initially received approval for use in one or two specific disorders based on large, well-designed clinical trials in carefully selected, medically healthy adult populations.1–6

J Clin Psychiatry 1998;59(suppl 1):3–4